Cookson Peirce & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Sell |
262,643
-373
| -0.1% | -$40.1K | 1.24% | 30 |
|
|
2025
Q1 | $26.5M | Buy |
263,016
+3,998
| +2% | +$403K | 1.33% | 27 |
|
|
2024
Q4 | $23.1M | Buy |
259,018
+1,813
| +0.7% | +$162K | 1.05% | 32 |
|
|
2024
Q3 | $21.6M | Buy |
257,205
+4,116
| +2% | +$345K | 1.01% | 33 |
|
|
2024
Q2 | $19.5M | Buy |
253,089
+1,192
| +0.5% | +$91.8K | 0.94% | 38 |
|
|
2024
Q1 | $17.3M | Sell |
251,897
-566
| -0.2% | -$38.8K | 0.92% | 37 |
|
|
2023
Q4 | $14.6M | Buy |
252,463
+10,551
| +4% | +$610K | 0.88% | 39 |
|
|
2023
Q3 | $12.8M | Buy |
241,912
+47,312
| +24% | +$2.5M | 0.84% | 43 |
|
|
2023
Q2 | $10.5M | Buy |
194,600
+160,377
| +469% | +$8.67M | 0.64% | 48 |
|
|
2023
Q1 | $1.71M | Buy |
+34,223
| New | +$1.71M | 0.11% | 81 |
|